![](/img/cover-not-exists.png)
Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report
Zhou, Qinfei, Zhao, Jiazheng, Wang, Jie, Bao, Guanai, Gong, Li-YanVolume:
9
Journal:
Annals of Palliative Medicine
DOI:
10.21037/apm-20-1244
Date:
July, 2020
File:
PDF, 1.23 MB
2020